The Impact of Nutritional Support on Survival Outcomes in Patients with Advanced Gastric Adenocarcinoma Treated with Chemotherapy

References

• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. doi: 10.3322/caac.21660. Cited in: PMID: 33538338.
   PubMed Web of Science ®Google Scholar
• Kang Y-K, Chen L-T, Ryu M-H, Oh D-Y, Oh SC, Chung HC, Lee K-W, Omori T, Shitara K, Sakuramoto S, et al. Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2022;23(2):234–47. doi: 10.1016/S1470-2045(21)00692-6. Cited in: PMID: 35030335. 10.1016/S1470-2045(21)00692-6
   PubMed Web of Science ®Google Scholar
• Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, Wyrwicz L, Yamaguchi K, Skoczylas T, Campos Bragagnoli A, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398(10294):27–40. doi:10.1016/S0140-6736(21)00797-2. Cited in: PMID: 34102137 10.1016/S0140-6736(21)00797-2
   PubMed Web of Science ®Google Scholar
• Janjigian YY, Kawazoe A, Yañez P, Li N, Lonardi S, Kolesnik O, Barajas O, Bai Y, Shen L, Tang Y, et al. The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer. Nature. 2021;600(7890):727–30. doi: 10.1038/s41586-021-04161-3. Cited in: PMID: 34912120.
   PubMed Web of Science ®Google Scholar
• Sugiyama K, Narita Y, Mitani S, Honda K, Masuishi T, Taniguchi H, Kadowaki S, Ura T, Ando M, Tajika M, et al. Baseline sarcopenia and skeletal muscle loss during chemotherapy affect survival outcomes in metastatic gastric cancer. Anticancer Res. 2018;38(10):5859–66. doi: 10.21873/anticanres.12928. Cited in: PMID: 30275211.
   PubMed Web of Science ®Google Scholar
• Dijksterhuis WPM, Pruijt MJ, van der Woude SO, Klaassen R, Kurk SA, van Oijen MGH, van Laarhoven HWM. Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy. J Cachexia Sarcopenia Muscle. 2019;10(1):199–206. doi: 10.1002/jcsm.12371. Cited in: PMID: 30666831.
   PubMed Web of Science ®Google Scholar
• Kubo Y, Miyata H, Sugimura K, Shinno N, Asukai K, Hasegawa S, Yanagimoto Y, Yamada D, Yamamoto K, Nishimura J, et al. Prognostic implication of postoperative weight loss after esophagectomy for esophageal squamous cell cancer. Ann Surg Oncol. 2021;28(1):184–93. doi: 10.1245/s10434-020-08762-6. Cited in: PMID: 32591956. 10.1245/s10434-020-08762-6
   PubMed Web of Science ®Google Scholar
• Marshall KM, Loeliger J, Nolte L, Kelaart A, Kiss NK. Prevalence of malnutrition and impact on clinical outcomes in cancer services: a comparison of two time points. Clin Nutr. 2019;38(2):644–51. doi: 10.1016/j.clnu.2018.04.007. Cited in: PMID: 29789167.
   PubMed Web of Science ®Google Scholar
• Li Y-F, Nie R-C, Wu T, Li S-M, Chen S, Wang W, Chen X-J, Chen G-M, Chen Y-B, Zhou Z-W, et al. Prognostic value of the Nutritional Risk Screening 2002 Scale in metastatic gastric cancer: a large-scale cohort study. J Cancer. 2019;10(1):112–9. doi: 10.7150/jca.27729. Cited in: PMID: 30662531.
   PubMed Web of Science ®Google Scholar
• Hsieh M-C, Wang S-H, Chuah S-K, Lin Y-H, Lan J, Rau K-M. A prognostic model using inflammation- and nutrition-based scores in patients with metastatic gastric adenocarcinoma treated with chemotherapy. Medicine (Baltimore). 2016;95(17):e3504. doi: 10.1097/MD.0000000000003504. Cited in: PMID: 27124056.
   PubMed Web of Science ®Google Scholar
• Guo ZQ, Yu JM, Li W, Fu ZM, Lin Y, Shi YY, Hu W, Ba Y, Li SY, Li ZN, Investigation on the Nutrition Status and Clinical Outcome of Common Cancers (INSCOC) Group, et al. Survey and analysis of the nutritional status in hospitalized patients with malignant gastric tumors and its influence on the quality of life. Support Care Cancer. 2020;28(1):373–80. doi: 10.1007/s00520-019-04803-3. Cited in: PMID: 31049672.
   PubMed Web of Science ®Google Scholar
• Argilés JM, Busquets S, Stemmler B, López-Soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 2014;14(11):754–62. doi: 10.1038/nrc3829. Cited in: PMID: 25291291.
   PubMed Web of Science ®Google Scholar
• Ongaro E, Buoro V, Cinausero M, Caccialanza R, Turri A, Fanotto V, Basile D, Vitale MG, Ermacora P, Cardellino GG, et al. Sarcopenia in gastric cancer: when the loss costs too much. Gastric Cancer. 2017;20(4):563–72. doi: 10.1007/s10120-017-0722-9. Cited in: PMID: 28477106.
   PubMed Web of Science ®Google Scholar
• Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hütterer E, Isenring E, Kaasa S, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36(1):11–48. doi: 10.1016/j.clnu.2016.07.015. Cited in: PMID: 27637832.
   PubMed Web of Science ®Google Scholar
• August DA, Huhmann MB, American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN J Parenter Enteral Nutr. 2009;33(5):472–500. doi: 10.1177/0148607109341804. Cited in: PMID: 19713551.
   PubMed Web of Science ®Google Scholar
• Arends J, Strasser F, Gonella S, Solheim TS, Madeddu C, Ravasco P, Buonaccorso L, de van der Schueren MAE, Baldwin C, Chasen M, ESMO Guidelines Committee. Electronic address: [email protected], et al. Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines. ESMO Open. 2021;6(3):100092. doi: 10.1016/j.esmoop.2021.100092. Cited in: PMID: 34144781.
   PubMed Web of Science ®Google Scholar
• Rinninella E, Cintoni M, Raoul P, Pozzo C, Strippoli A, Bria E, Tortora G, Gasbarrini A, Mele MC. Effects of nutritional interventions on nutritional status in patients with gastric cancer: a systematic review and meta-analysis of randomized controlled trials. Clin Nutr ESPEN. 2020;38:28–42. doi: 10.1016/j.clnesp.2020.05.007. Cited in: PMID: 32690170.
   PubMed Web of Science ®Google Scholar
• Xie F-L, Wang Y-Q, Peng L-F, Lin F-Y, He Y-L, Jiang Z-Q. Beneficial effect of educational and nutritional intervention on the nutritional status and compliance of gastric cancer patients undergoing chemotherapy: a randomized trial. Nutr Cancer. 2017;69(5):762–71. doi: 10.1080/01635581.2017.1321131. Cited in: PMID: 28524705.
   PubMed Web of Science ®Google Scholar
• Kim H, Suh EE, Lee H-J, Yang H-K. The effects of patient participation-based dietary intervention on nutritional and functional status for patients with gastrectomy: a randomized controlled trial. Cancer Nurs. 2014;37(2):E10–20. doi: 10.1097/NCC.0b013e31829193c8. Cited in: PMID: 23632471.
   PubMed Web of Science ®Google Scholar
• Hur H, Kim SG, Shim JH, Song KY, Kim W, Park CH, Jeon HM. Effect of early oral feeding after gastric cancer surgery: a result of randomized clinical trial. Surgery. 2011;149(4):561–8. doi: 10.1016/j.surg.2010.10.003. Cited in: PMID: 21146844.
   PubMed Web of Science ®Google Scholar
• Trestini I, Carbognin L, Sperduti I, Bonaiuto C, Auriemma A, Melisi D, Salvatore L, Bria E, Tortora G. Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy. Eur J Clin Nutr. 2018;72(5):772–9. doi: 10.1038/s41430-018-0155-5. Cited in: PMID: 29581564.
   PubMed Web of Science ®Google Scholar
• Chen F, Fang J, Wang H, Song T, Zhu W, Wu M, Wu Y. Effects of nutritional support on short-term clinical outcomes and immune response in unresectable locally advanced oesophageal squamous cell carcinoma. Eur J Cancer Care (Engl). 2018;27(2):e12818. doi: 10.1111/ecc.12818. Cited in: PMID: 29345017.
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228–47. doi: 10.1016/j.ejca.2008. Cited in: PMID: 19097774.
   PubMed Web of Science ®Google Scholar
• U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. CTCAE v5.0 Quick Reference 5x7. National Cancer Institute Division of Cancer Treatment and Diagnosis; 2017. [accessed October 26 2021]. https://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_5x7.pdf.
   Google Scholar
• Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer. 2003;89(6):1028–30. doi: 10.1038/sj.bjc.6601242. Cited in: PMID: 12966420.
   PubMed Web of Science ®Google Scholar
• Li Q-Q, Lu Z-H, Yang L, Lu M, Zhang X-T, Li J, Zhou J, Wang X-C, Gong J-F, Gao J, et al. Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy. Asian Pac J Cancer Prev. 2014;15(2):945–50. doi: 10.7314/apjcp.2014.15.2.945. Cited in: PMID: 24568523.
   PubMedGoogle Scholar
• Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48(3):452–8. doi: 10.1038/bmt.2012.244. Cited in: PMID: 23208313.
   PubMed Web of Science ®Google Scholar
• Demirelli B, Babacan NA, Ercelep Ö, Öztürk MA, Kaya S, Tanrıkulu E, Khalil S, Hasanov R, Alan Ö, Telli TA, et al. Modified Glasgow Prognostic Score, prognostic nutritional index and ECOG performance score predicts survival better than sarcopenia, cachexia and some inflammatory indices in metastatic gastric cancer. Nutr Cancer. 2021;73(2):230–8. doi: 10.1080/01635581.2020.1749290. Cited in: PMID: 32270713.
   PubMed Web of Science ®Google Scholar
• Sachlova M, Majek O, Tucek S. Prognostic value of scores based on malnutrition or systemic inflammatory response in patients with metastatic or recurrent gastric cancer. Nutr Cancer. 2014;66(8):1362–70. doi: 10.1080/01635581.2014.956261. Cited in: PMID: 25356861.
   PubMed Web of Science ®Google Scholar
• Fukahori M, Shibata M, Hamauchi S, Kasamatsu E, Machii K. A retrospective cohort study to investigate the incidence of cancer-related weight loss during chemotherapy in gastric cancer patients. Support Care Cancer. 2021;29(1):341–8. doi: 10.1007/s00520-020-05479-w. Cited in: PMID: 32361831.
   PubMed Web of Science ®Google Scholar
• Mizukami T, Hamaji K, Onuki R, Yokomizo A, Nagashima Y, Takeda H, Umemoto K, Doi A, Arai H, Hirakawa M, et al. Impact of body weight loss on survival in patients with advanced gastric cancer receiving second-line treatment. Nutr Cancer. 2022;74(2):539–45. doi: 10.1080/01635581.2021.1902542. Cited in: PMID: 33754895.
   PubMed Web of Science ®Google Scholar
• Ock C-Y, Oh D-Y, Lee J, Kim T-Y, Lee K-H, Han S-W, Im S-A, Kim T-Y, Bang Y-J. Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer. Gastric Cancer. 2016;19(2):597–606. doi: 10.1007/s10120-015-0481-4. Cited in: PMID: 25749718.
   PubMed Web of Science ®Google Scholar
• Baldwin C, Spiro A, McGough C, Norman AR, Gillbanks A, Thomas K, Cunningham D, O’Brien M, Andreyev HJN. Simple nutritional intervention in patients with advanced cancers of the gastrointestinal tract, non-small cell lung cancers or mesothelioma and weight loss receiving chemotherapy: a randomised controlled trial. J Hum Nutr Diet. 2011;24(5):431–40. doi: 10.1111/j.1365-277X.2011.01189.x. Cited in: PMID: 21733143.
   PubMed Web of Science ®Google Scholar
• Bourdel-Marchasson I, Blanc-Bisson C, Doussau A, Germain C, Blanc J-F, Dauba J, Lahmar C, Terrebonne E, Lecaille C, Ceccaldi J, et al. Nutritional advice in older patients at risk of malnutrition during treatment for chemotherapy: a two-year randomized controlled trial. PLoS One. 2014;9(9):e108687. doi: 10.1371/journal.pone.0108687. Cited in: PMID: 25265392.
   PubMed Web of Science ®Google Scholar
• Lu Z, Fang Y, Liu C, Zhang X, Xin X, He Y, Cao Y, Jiao X, Sun T, Pang Y, et al. Early Interdisciplinary supportive care in patients with previously untreated metastatic esophagogastric cancer: a phase III randomized controlled trial. J Clin Oncol. 2021;39(7):748–56. doi: 10.1200/JCO.20.01254. Cited in: PMID: 33417481.
   PubMed Web of Science ®Google Scholar
• Kang Y-K, Boku N, Satoh T, Ryu M-H, Chao Y, Kato K, Chung HC, Chen J-S, Muro K, Kang WK, et al. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;390(10111):2461–71. doi: 10.1016/S0140-6736(17)31827-5. Cited in: PMID: 28993052. 10.1016/S0140-6736(17)31827-5
   PubMed Web of Science ®Google Scholar
• Kim Y-Y, Lee J, Jeong WK, Kim ST, Kim J-H, Hong JY, Kang WK, Kim K-M, Sohn I, Choi D. Prognostic significance of sarcopenia in microsatellite-stable gastric cancer patients treated with programmed death-1 inhibitors. Gastric Cancer. 2021;24(2):457–66. doi:10.1007/s10120-020-01124-x. Cited in: PMID: 32970267.
   PubMed Web of Science ®Google Scholar
• Fujii H, Makiyama A, Iihara H, Okumura N, Yamamoto S, Imai T, Arakawa S, Kobayashi R, Tanaka Y, Yoshida K, et al. Cancer cachexia reduces the efficacy of nivolumab treatment in patients with advanced gastric cancer. Anticancer Res. 2020;40(12):7067–75. doi: 10.21873/anticanres.14734. Cited in: PMID: 33288604.
   PubMed Web of Science ®Google Scholar
• Quiroz-Olguín G, Gutiérrez-Salmeán G, Posadas-Calleja JG, Padilla-Rubio MF, Serralde-Zúñiga AE. The effect of enteral stimulation on the immune response of the intestinal mucosa and its application in nutritional support. Eur J Clin Nutr. 2021;75(11):1533–9. doi: 10.1038/s41430-021-00877-7. Cited in: PMID: 33608653.
   PubMed Web of Science ®Google Scholar
• De Waele E, Demol J, Caccialanza R, Cotogni P, Spapen H, Malbrain ML, De Grève J, Pen JJ. Unidentified cachexia patients in the oncologic setting: Cachexia UFOs do exist. Nutrition. 2019;63-64:200–4. doi: 10.1016/j.nut.2019.02.015. Cited in: PMID: 31029048.
   PubMed Web of Science ®Google Scholar
• Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733–42. doi: 10.1056/NEJMoa1000678. Cited in: PMID: 20818875.
   PubMed Web of Science ®Google Scholar